Company: SHPH
Filing Date: 2025-10-21
Form Type: 8-K
Source: 0001493152-25-018788
Chunk: 0

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-10-21
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item
1.01 Entry into a Material Definitive Agreement.

On
October 20, 2025, Shuttle Pharmaceuticals Holdings, Inc. (the “ Company”) entered into a binding term sheet with 1542770 BC
Ltd. (“ Molecule”). The term sheet sets forth the material business terms of a transaction under which the Company or its
affiliate will purchase from Molecule substantially all of Molecule’s assets and liabilities for a purchase price of $10,000,000
payable in a combination of cash and shares of common stock of the Company (which combination of cash and common stock is subject to
the Company’s sole determination) over time and subject to the achievement of certain milestones. The parties agreed that they
will enter into one or more written agreements embodying the terms of the term sheet and effectuating the transactions contemplated thereby,
that will address in further detail the matters covered by the term sheet, together with additional customary terms and conditions regarding
the transaction. Completion of the transaction will be subject to, among other customary conditions, negotiation and execution of such
definitive agreements, approval of the Company’s board of directors, and completion of due diligence by both parties.

The
foregoing description of the term sheet is qualified by reference to the full text of such document which is filed as an exhibit to this
report and incorporated by reference herein.

Item
1.02 Termination of a Material Definitive Agreement.